Oriola-KD Corporation published the interim report 1 January - 30 June 2015 on Friday, 17 July 2015 at 8.30 a.m.
President and CEO Eero Hautaniemi's comments regarding the interim report:
"The first half of the year net sales and operating profit excluding non-recurring items of the Swedish businesses remained at the level of the corresponding period, on a constant currency basis operating profit excluding non-recurring items increased by EUR 1.1 million. Profitability of the Swedish retail business was negatively affected by significant decrease of parallel import from the corresponding period and price cuts set by TLV (Tandvårds- och läkemedelsförmånsverket) in fourth quarter of 2014 and on June 1, 2015. Net sales of the Swedish wholesale business was supported by the new agreements with pharmaceutical companies signed in 2014. In accordance with our strategy we will open an online pharmacy in Sweden during the second half of the year.
In Finnish wholesale business we renewed significant long term cooperation agreements with Orion and Boehringer Ingelheim.
In the second quarter we made an agreement regarding the rearrangement of our long-term revolving credit facility and term loan agreement."